Assessing the potential for Staphylococcus aureus to evolve resistance to XF-73
Antibiotic resistance in pathogenic bacteria has emerged as a fundamental threat to human health by increasing the mortality rates and economic costs associated with bacterial infections. The commensal pathogen Staphylococcus aureus provides a clear illustration of the antimicrobial resistance (AMR)...
Main Author: | Maclean, RC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Cell Press
2020
|
Similar Items
-
Screening of the novel antimicrobial drug, XF-73, against 2,527 Staphylococcus species clinical isolates
by: William Rhys-Williams, et al.
Published: (2023-10-01) -
Assessment of the potential for resistance to antimicrobial violet-blue light in Staphylococcus aureus
by: Rachael M. Tomb, et al.
Published: (2017-09-01) -
Efficacy of a Novel Antibacterial Agent Exeporfinium Chloride, (XF-73), Against Antibiotic-Resistant Bacteria in Mouse Superficial Skin Infection Models
by: Zhang C, et al.
Published: (2023-07-01) -
Evolving rapid methicillin-resistant Staphylococcus aureus detection: Cover all the bases
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2017-01-01) -
Proteome profiling of evolved methicillin-resistant Staphylococcus aureus strains with distinct daptomycin tolerance and resistance phenotypes
by: Jordy Evan Sulaiman, et al.
Published: (2022-08-01)